Skip to main content
Log in

The HSP co-inducer BGP-15 can prevent the metabolic side effects of the atypical antipsychotics

  • Short Communication
  • Published:
Cell Stress and Chaperones Aims and scope

Abstract

Weight gain and dysfunction of glucose and lipid metabolism are well-known side effects of atypical antipsychotic drugs (AAPD). Here, we address the question whether a heat-shock protein (HSP) co-inducer, insulin sensitizer drug candidate, BGP-15, can prevent AAPD-induced glucose, lipid, and weight changes. We also examined how an AAPD alters HSP expression and whether BGP-15 alters that expression. Four different experiments are reported on the AAPD BGP-15 interventions in a human trial of healthy men, a rodent animal model, and an in vitro adipocyte cell culture system. Olanzapine caused rapid insulin resistance in healthy volunteers and was associated with decreased level of HSP72 in peripheral mononuclear blood cells. Both changes were restored by the administration of BGP-15. In Wistar rats, weight gain and insulin resistance induced by clozapine were abolished by BGP-15. In 3T3L1 adipocytes, clozapine increased intracellular fat accumulation, and BGP-15 inhibited this process. Taken together, our results indicate that BGP-15 inhibits multiple metabolic side effects of atypical antipsychotics, and this effect is likely to be related to its HSP co-inducing ability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig.4

References

  • Allison DB et al (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156:1686

    PubMed  CAS  Google Scholar 

  • American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry 65:267–272

    Article  Google Scholar 

  • Balogh G, Horváth I, Nagy E, Hoyk Z, Benkõ S, Bensaude O, Vígh L (2005) The hyperfluidization of mammalian cell membranes acts as a signal to initiate the heat shock protein response. FEBS J 272:6077–6086

    Article  PubMed  CAS  Google Scholar 

  • Balogh G, Péter M, Liebisch G, Horváth I, Török Z, Nagy E, Maslyanko A, Benkő S, Schmitz G, Harwood JL, Vígh L (2010) Lipidomics reveals membrane lipid remodelling and release of potential lipid mediators during early stress responses in a murine melanoma cell line. Biochim Biophys Acta 1801:1036–1047

    PubMed  CAS  Google Scholar 

  • Baptista T, Martínez J, Lacruz A, Rangel N, Beaulieu S, Serrano A, Arapé Y, Martinez M, de Mendoza S, Teneud L, Hernández L (2006) Metformin for prevention of weight gain and insulin resistance with olanzapine: a double bind placebo-controlled trial. Can J Psychiatry 51:192–196

    PubMed  Google Scholar 

  • Chung J, Nguyen AK, Henstridge DC, Holmes AG, Chan MH, Mesa JL, Lancaster GI, Southgate RJ, Bruce CR, Duffy SJ, Horvath I, Mestril R, Watt MJ, Hooper PL, Kingwell BA, Vigh L, Hevener A, Febbraio MA (2008) HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci USA 105:1739–1744

    Article  PubMed  CAS  Google Scholar 

  • Cooper GD, Pickavance LC, Wilding JP, Halford JC, Goudie AJ (2005) A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology (Berl) 181:80–89

    Article  CAS  Google Scholar 

  • Dwyer DS, Donohoe D (2003) Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake. Pharmacol Biochem Behav 75:255–260

    Article  PubMed  CAS  Google Scholar 

  • Giri S, Rattan R, Haq E, Khan M, Yasmin R, Won J, Key L, Singh AK, Singh I (2006) ICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr Metab (Lond) 3:31

    Article  Google Scholar 

  • Gombos I, Crul T, Piotto S, Güngör B, Török Z, Balogh G, Péter M, Slotte PJ, Pilbat AN, Hunya A, Tóth N, Literati-Nagy Z, Vigh L, Jr, Glatz A, Brameshuber, M, Schütz GJ, Hevener A, Febbraio MA, Horváth I, Vígh L (2011) Membrane-lipid therapy in operation: the HSP co-inducer BGP-15 activates stress signal transduction pathways by remodeling plasma membrane rafts. PLoS ONE 6(12):e28818

  • Gupte AA, Bomhoff GL, Swerdlow RH, Geiger PC (2009a) Heat treatment improves glucose tolerance and prevents skeletal muscle insulin resistance in rats fed a high-fat diet. Diabetes 58:567–578

    Article  Google Scholar 

  • Gupte AA, Bomhoff GL, Morris J, Gorres BK, Geiger PC (2009b) Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high-fat-fed rats. J Appl Physiol 106:1425–1434

    Article  CAS  Google Scholar 

  • Hooper PL, Hooper JJ (2005) Loss of defense against stress: diabetes and heat shock proteins. Diabetes Technol Ther 7:204–208

    Article  PubMed  CAS  Google Scholar 

  • Hooper PL, Hooper PL (2009) Inflammation, heat shock proteins, and type 2 diabetes. Cell Stress Chaperones 14:113–115

    Article  PubMed  CAS  Google Scholar 

  • Kim E, Park DW, Choi SH, Kim JJ, Cho HS (2008) A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia. J Clin Psychopharmacol 28:138–146

    Article  PubMed  CAS  Google Scholar 

  • Lambert BL, Cunningham FE, Miller DR, Dalack GW, Hur K (2006) Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia. Am J Epidemiol 164:672–681

    Article  PubMed  Google Scholar 

  • Lee YH, Chen SY, Wiesner RJ, Huang YF (2004) Simple flow cytometric method used to assess lipid accumulation in fat cells. J Lipid Res 45:1162–1167

    Article  PubMed  CAS  Google Scholar 

  • Literáti-Nagy B, Kulcsár E, Literáti-Nagy Z, Buday B, Péterfai E, Horváth T, Tory K, Kolonics A, Fleming A, Mandl J, Korányi L (2009) Improvement of insulin sensitivity by a novel drug, BGP-15, in insulin-resistant patients: a proof of concept randomized double-blind clinical trial. Horm Metab Res 41:374–380

    Article  PubMed  Google Scholar 

  • Literáti-Nagy B, Péterfai E, Kulcsár E, Literáti-Nagy Z, Buday B, Tory K, Mandl J, Sümegi B, Fleming A, Roth J, Korányi L (2010) Beneficial effect of the insulin sensitizer (HSP co-inducer) BGP-15 on olanzapine-induced metabolic disorders. Brain Res Bull 83:340–344

    Article  PubMed  Google Scholar 

  • Mandl J, Mészáros T, Bánhegyi G, Hunyady L, Csala M (2009) Endoplasmic reticulum: nutrient sensor in physiology and pathology. Trends Endocrinol Metab 20:194–201

    Article  PubMed  CAS  Google Scholar 

  • Nagy E, Balogi Z, Gombos I, Akerfelt M, Björkbom A, Balogh G, Török Z, Maslyanko A, Fiszer-Kierzkowska A, Lisowska K, Slotte PJ, Sistonen L, Horváth I, Vígh L (2007) Hyperfluidization-coupled membrane microdomain reorganization is linked to activation of the heat shock response in a murine melanoma cell line. Proc Natl Acad Sci USA 104:7945–7950

    Article  PubMed  CAS  Google Scholar 

  • Nagy G, Szarka A, Lotz G, Dóczi J, Wunderlich L, Kiss A, Jemnitz K, Veres Z, Bánhegyi G, Schaff Z, Sümegi B, Mandl J (2010) BGP-15 inhibits caspase-independent programmed cell death in acetaminophen-induced liver injury. Toxicol Appl Pharmacol 243:96–103

    Article  PubMed  CAS  Google Scholar 

  • Török Z, Tsvetkova NM, Balogh G, Horváth I, Nagy E, Pénzes Z, Hargitai J, Bensaude O, Csermely P, Crowe JH, Maresca B, Vigh L (2003) Heat shock protein co-inducers with no effect on protein denaturation specifically modulate the membrane lipid phase. Proc Natl Acad Sci USA 100:3131–3136

    Article  PubMed  Google Scholar 

  • Vígh L, Literáti PN, Horváth I, Török Z, Balogh G, Glatz A, Kovács E, Boros I, Ferdinándy P, Farkas B, Jaszlits L, Jednákovits A, Korányi L, Maresca B (1997) Bimoclomol: a nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects. Nat Med 3:1150–1154

    Article  PubMed  Google Scholar 

  • Vígh L, Maresca B, Harwood J (1998) Does the membrane’s physical state control the expression of heat shock and other genes? Trends Biochem Sci 23:369–373

    Article  PubMed  Google Scholar 

  • Vígh L, Horváth I, Maresca B, Harwood J (2007) Can the stress protein response be controlled by ‘membrane-lipid therapy’? Trends Biochem Sci 32:357–363

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Funding was in part from grants from the Hungarian National Scientific Research Foundation, OTKA NN 76716.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Philip L. Hooper or László Vígh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Literáti-Nagy, Z., Tory, K., Literáti-Nagy, B. et al. The HSP co-inducer BGP-15 can prevent the metabolic side effects of the atypical antipsychotics. Cell Stress and Chaperones 17, 517–521 (2012). https://doi.org/10.1007/s12192-012-0327-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12192-012-0327-5

Keywords

Navigation